Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA sharp sting during or after a Mounjaro injection is common, and for most people it settles within a minute or two. The sensation usually comes from the medicine's pH or the temperature of the pen, not from anything going wrong. That said, understanding what's behind the sting — and when it means something worth acting on — is worth knowing before your next dose. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who experience a pronounced sting assume they have chosen the wrong spot, pressed too hard, or injected too quickly. The reality is more straightforward. Tirzepatide has a specific pH and an inactive ingredient profile that, for some people, triggers a mild burning sensation on contact with subcutaneous tissue. This is a property of the formulation itself, not evidence of user error. Clinical trial participants reported injection-site reactions (including stinging and discomfort) as a recognised occurrence, and the NHS tirzepatide patient information page lists injection-site pain and redness among the known side effects described by NHS medicines guidance.
Speed does play a role, though. A very fast injection delivers the medicine in a concentrated burst; a slower, steadier press of the button distributes it more gradually and often reduces the sharp initial sensation. If you have been injecting quickly from the start, trying a slower technique is one of the simplest adjustments available. Our prescribers hear this question most weeks, and slower delivery is nearly always the first practical change worth trying before considering anything else.
The pen temperature matters just as much. Storing Mounjaro in the fridge is necessary, but injecting immediately after taking it out means the medicine goes in cold. Cold subcutaneous tissue is more sensitive, and a cold solution stings more than a room-temperature one. Give the pen around 30 minutes on a clean, cool surface before use (not in sunlight or near a heat source) and most people notice a real difference. Always check the Mounjaro Patient Information Leaflet for precise storage and handling guidance, as the permitted room-temperature window is specific to this medicine.
Where you inject affects how much you feel. The abdomen tends to have more subcutaneous fat and is the site many people find most comfortable, but if you have been using the same small area repeatedly, the tissue can become sensitised. Rotating your injection sites (moving systematically around the abdomen, switching to the thigh, or using the upper arm) gives each area time to recover between doses. Our full guide to choosing your injection site covers the approved areas and how to map a sensible rotation.
Skin that is irritated, sunburned, scarred or recently bruised will always sting more than healthy tissue. Injecting into hard or lumpy skin (lipohypertrophy, which develops when any area is used too often) is another common cause of increased discomfort and can also affect how consistently the medicine is absorbed. If you notice firm patches under the skin where you have been injecting, avoid that area and let it recover. Cleaning the site with an alcohol swab and allowing it to dry fully before injecting also reduces stinging, wet skin with residual alcohol is a reliably uncomfortable combination.
The upper arm as an injection site is an option when you want to give the abdomen or thigh a rest, though it requires either a second pair of hands or a steady technique to reach comfortably. Some people find it slightly more uncomfortable there; others prefer it. What matters is that the injection goes into subcutaneous fat, not muscle.
Most injection-site stinging resolves within minutes and leaves nothing behind. The reactions that warrant a closer look behave differently: redness that spreads rather than fades, swelling or warmth that is still there the next day, or skin that becomes harder or darker around the injection point. These are not the typical brief discomfort of a normal injection and are worth mentioning to a clinician. Likewise, any sign of an allergic reaction (itching beyond the injection spot, hives, swelling of the face or throat, or difficulty breathing) requires prompt medical attention.
Injection-site reactions were tracked carefully in Mounjaro's clinical programme, and the MHRA's Drug Safety Update communications are the reference point for safety signals that emerge post-approval. If you are uncertain whether what you are experiencing is within normal range, the Patient Information Leaflet is your first reference, and your prescriber is the right person to ask. At nume, aftercare is available seven days a week, so there is no need to wait until your next scheduled check-in if something is bothering you, contact the team and someone will get back to you the same day.
If you are new to the process and want a clearer picture of how injections work from the start, the overview of Mounjaro injections covers technique, preparation and what to expect in more detail. Questions about whether rotating sites affects how the medicine works are also worth reading through, absorption is more consistent than many people expect across the approved locations.
To summarise the evidence-based steps that reduce injection-site stinging: take the pen out of the fridge around 30 minutes before you need it; let the injection site dry fully after cleaning; press the button slowly and steadily rather than jabbing; rotate systematically so no single area is used more than once every few weeks; and check the skin before you inject, avoid any spot that is already tender, red or firm. None of these steps require additional equipment or a change to your prescribed dose.
The separate guide on injection-site redness goes into more detail about what normal post-injection redness looks like versus reactions that need assessment. If you are weighing up where to inject week to week, the question of adjusting your injection day (which can sometimes change the window you have before the next dose) is a separate but related practical consideration your prescriber can advise on. For anyone researching tirzepatide for the first time, the Mounjaro treatment overview covers the full picture, from eligibility to how the medicine works. And if you are at the stage of comparing your options, a look at what Mounjaro costs through different UK providers sets out the landscape honestly.
If you are not yet on treatment and want to find out whether tirzepatide is suitable for you, check your eligibility with a free consultation, a GPhC-registered prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.